Publicatie

Publicatie datum

Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42 (19) (2024).

Laniece Delaunay, C., Melo, A., Maurel, M., Mazagatos, C., Goerlitz, L., O'Donnell, J., Oroszi, B., Sève, N., Rodrigues, A.P., Martínez-Baz, I., Meijer, A., Mlinarić, I., Latorre-Margalef, N., Lazar, M., Pérez-Gimeno, G., Dürrwald, R., Bennett, C., Túri, G., Rameix-Welti, M.A., Guiomar, R., Castilla, J., Hooiveld, M., Kurečić Filipović, S., Samuelsson Hagey, T., Dijkstra, F., Borges, V., Ramos Marín, V., Bacci, S., Kaczmarek, M., Kissling, E. Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42 (19) (2024). Vaccine: 2024
Lees online
The authors regret that there was an error in two dates in Table 1, which includes autumn 2023 national COVID-19 vaccination campaign dates by study site. We update here the date for Germany, which was 18 September 2023, and for Navarre, Spain, which was 16 October, 2023. These dates were used in the analysis, so the error in Table 1 does not affect results or findings. The corrected Table 1 is as follows:
Table 1. Autumn 2023 national COVID-19 vaccination campaign, vaccination and recruitment information, by study site, VEBIS primary care study, September 2023–January 2024